No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract Brentuximab Vedotin is a safe and effective treatment in patients with Mycosis Fungoides and Sezary Syndrome

byKathleen Lau

June 24, 2021

in StudyGraphics

Proton therapy associated with reduced toxicity and equivalent survival outcomes vs radiation therapy amongst patients with nonmetastatic nasopharygneal carcinoma

RelatedReports

Patients with advanced adenomas are at increased risk of developing colorectal cancer

AI Roundup

AstraZeneca moves to own multimodal oncology AI with Modella

January 21, 2026

AI Roundup

2MM: AI Roundup – Lilly and NVIDIA’s $1B AI lab, Illumina’s Billion Cell Atlas, AstraZeneca’s Modella deal, and Claude for Healthcare [Jan 19th, 2026]

January 19, 2026

Testosterone replacement in male cancer survivors helps improve body composition

Oncology

New model enhances prediction of prostate cancer-specific mortality

January 12, 2026

2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]

Cardiology

2 Minute Medicine: Pharma Roundup – New oral gonorrhea antibiotic Nuzolvence (zoliflodacin), late‑December cardiovascular and oncology drug approvals, first targeted complement inhibitor therapy for HSCT‑TMA (Yartemlea), and antibody‑drug conjugate (ADC) safety concerns with ifinatamab deruxtecan (I‑DXd) [January 2026]

January 12, 2026

Conventional cardiovascular risk assessments may overestimate risk in populations with widespread diabetes screening guidelines

CHADS-VASc score may help predict outcomes in heart failure

Burden of ischemic stroke increased in patients with congenital heart disease

Thrombophilia-associated stillbirth risk appears limited to factor V Leiden

Bridging with low molecular weight heparin may not be beneficial for patients with atrial fibrillation or mechanical heart valves

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports